| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 60.173 | 395.867 | 732.579 | 439.771 | 180.294 |
| Total Income - EUR | - | - | - | - | - | 61.931 | 395.951 | 732.666 | 439.771 | 176.198 |
| Total Expenses - EUR | - | - | - | - | - | 61.205 | 378.868 | 723.378 | 432.513 | 163.388 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 725 | 17.083 | 9.288 | 7.257 | 12.810 |
| Net Profit/Loss - EUR | - | - | - | - | - | 115 | 13.123 | 1.960 | 6.120 | 11.348 |
| Employees | - | - | - | - | - | 9 | 9 | 13 | 5 | 8 |
Check the financial reports for the company - Mdm Bogson Laboratorium S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 5.132 | 6.305 | 19.650 | 19.745 | 51.490 |
| Current Assets | - | - | - | - | - | 4.093 | 43.873 | 105.641 | 36.479 | 17.029 |
| Inventories | - | - | - | - | - | 0 | 7.185 | 20.010 | 9.412 | 1.967 |
| Receivables | - | - | - | - | - | 2.908 | 34.607 | 79.300 | 24.458 | 14.631 |
| Cash | - | - | - | - | - | 1.185 | 2.080 | 6.332 | 2.609 | 431 |
| Shareholders Funds | - | - | - | - | - | 157 | 13.276 | 2.009 | 8.123 | 15.406 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 11.396 | 36.902 | 123.282 | 48.101 | 53.113 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Mdm Bogson Laboratorium S.r.l.